Skip to content
10-Q

Quarterly Report

Inari Medical, Inc.

0001531048-24-000060

← back to feed
Filed
Oct 28, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Oct 24, 2024 58.54M sh
Shares Diluted Q3 2024 · Sep 30, 2024 58.37M sh
Shares Diluted Q3 2024 · Sep 30, 2024 58.15M sh
Shares Diluted Q3 2024 · Sep 30, 2023 58.59M sh
Shares Diluted Q3 2024 · Sep 30, 2023 58.5M sh
Capex Q3 2024 · Sep 30, 2024 $7.9M
Capex Q3 2024 · Sep 30, 2023 $3.8M
Operating Cash Flow Q3 2024 · Sep 30, 2024 $1.94M
Operating Cash Flow Q3 2024 · Sep 30, 2023 $23.69M
Cash And Equivalents Q3 2024 · Sep 30, 2024 $41.14M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $38.6M
Cash And Equivalents Q3 2024 · Sep 30, 2023 $89.18M
Stockholders Equity Q3 2024 · Sep 30, 2024 $434.76M
Stockholders Equity Q3 2024 · Jun 30, 2024 $423.81M
Stockholders Equity Q3 2024 · Mar 31, 2024 $447.23M
Stockholders Equity Q3 2024 · Dec 31, 2023 $464.91M
Stockholders Equity Q3 2024 · Sep 30, 2023 $452.14M
Stockholders Equity Q3 2024 · Jun 30, 2023 $435.65M
Stockholders Equity Q3 2024 · Mar 31, 2023 $426.74M
Stockholders Equity Q3 2024 · Dec 31, 2022 $417M
Current Liabilities Q3 2024 · Sep 30, 2024 $148.78M
Current Liabilities Q3 2024 · Dec 31, 2023 $76.34M
Total Liabilities Q3 2024 · Sep 30, 2024 $262.48M
Total Liabilities Q3 2024 · Dec 31, 2023 $209.33M
Current Assets Q3 2024 · Sep 30, 2024 $263.39M
Current Assets Q3 2024 · Dec 31, 2023 $235.56M
Total Assets Q3 2024 · Sep 30, 2024 $697.24M
Total Assets Q3 2024 · Dec 31, 2023 $674.24M
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.31
Eps Diluted Q3 2024 · Sep 30, 2024 −$1.27
Eps Diluted Q3 2024 · Sep 30, 2023 $0.05
Eps Diluted Q3 2024 · Sep 30, 2023 $0.05
Eps Basic Q3 2024 · Sep 30, 2024 −$0.31
Eps Basic Q3 2024 · Sep 30, 2024 −$1.27
Eps Basic Q3 2024 · Sep 30, 2023 $0.06
Eps Basic Q3 2024 · Sep 30, 2023 $0.05
Sga Expense Q3 2024 · Sep 30, 2024 $108.27M
Sga Expense Q3 2024 · Sep 30, 2024 $325.48M
Sga Expense restated Q3 2024 · Sep 30, 2023 $85.6M
Sga Expense restated Q3 2024 · Sep 30, 2023 $256.89M
Rd Expense Q3 2024 · Sep 30, 2024 $29.43M
Rd Expense Q3 2024 · Sep 30, 2024 $81.22M
Rd Expense Q3 2024 · Sep 30, 2023 $21.49M
Rd Expense Q3 2024 · Sep 30, 2023 $64.64M
Net Income Q3 2024 · Sep 30, 2024 −$18.37M
Net Income Q3 2024 · Sep 30, 2024 −$73.92M
Net Income Q3 2024 · Jun 30, 2024 −$31.35M
Net Income Q3 2024 · Mar 31, 2024 −$24.2M
Net Income Q3 2024 · Sep 30, 2023 $3.16M
Net Income Q3 2024 · Sep 30, 2023 $3.03M
Net Income Q3 2024 · Jun 30, 2023 $2.09M
Net Income Q3 2024 · Mar 31, 2023 −$2.22M
Operating Income Q3 2024 · Sep 30, 2024 −$13.57M
Operating Income Q3 2024 · Sep 30, 2024 −$53.19M
Operating Income Q3 2024 · Sep 30, 2023 $2.11M
Operating Income Q3 2024 · Sep 30, 2023 −$4.74M
Gross Profit Q3 2024 · Sep 30, 2024 $133.54M
Gross Profit Q3 2024 · Sep 30, 2024 $383.67M
Gross Profit Q3 2024 · Sep 30, 2023 $111.89M
Gross Profit Q3 2024 · Sep 30, 2023 $319.48M
Cost Of Revenue Q3 2024 · Sep 30, 2024 $19.85M
Cost Of Revenue Q3 2024 · Sep 30, 2024 $58.73M
Cost Of Revenue Q3 2024 · Sep 30, 2023 $14.48M
Cost Of Revenue Q3 2024 · Sep 30, 2023 $42.06M
Revenue Q3 2024 · Sep 30, 2024 $153.39M
Revenue Q3 2024 · Sep 30, 2024 $442.4M
Revenue Q3 2024 · Sep 30, 2023 $126.37M
Revenue Q3 2024 · Sep 30, 2023 $361.54M